Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Maternal weight gain adequacy is associated with newborn birth weight in gestational diabetes mellitus

Authors: Livia Silveira Mastella, Leticia Schwerz Weinert, Vanessa Gnielka, Vânia Naomi Hirakata, Maria Lúcia Rocha Oppermann, Sandra Pinho Silveiro, Angela de Azevedo Jacob Reichelt

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Gestational diabetes mellitus (GDM) is diagnosed in up to 18% of Brazilian women and is commonly related to pre-gestational obesity; superimposed weight gain during pregnancy may adversely contribute to maternal and fetal outcomes. …
Metadata
Title
Maternal weight gain adequacy is associated with newborn birth weight in gestational diabetes mellitus
Authors
Livia Silveira Mastella
Leticia Schwerz Weinert
Vanessa Gnielka
Vânia Naomi Hirakata
Maria Lúcia Rocha Oppermann
Sandra Pinho Silveiro
Angela de Azevedo Jacob Reichelt
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A81

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine